FDA Delays Approval Of Mercks HPV Vaccine Gardasil For Older Women
FDA has delayed a decision on Merck’s application to expand marketing of its human papillomavirus vaccine Gardasil to women ages 27 to 45, the company said Wednesday, the Newark Star-Ledger reports (Newark Star-Ledger, 6/26).
